KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $173.4 billion.

  • Cvs Health's Total Non-Current Liabilities rose 77.01% to $173.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $173.4 billion, marking a year-over-year increase of 77.01%. This contributed to the annual value of $173.4 billion for FY2025, which is 77.01% up from last year.
  • According to the latest figures from Q4 2025, Cvs Health's Total Non-Current Liabilities is $173.4 billion, which was up 77.01% from $177.5 billion recorded in Q3 2025.
  • Cvs Health's 5-year Total Non-Current Liabilities high stood at $177.5 billion for Q3 2025, and its period low was $149.8 billion during Q4 2022.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $168.1 billion (2023), whereas its average is $164.6 billion.
  • As far as peak fluctuations go, Cvs Health's Total Non-Current Liabilities plummeted by 579.2% in 2021, and later skyrocketed by 1186.83% in 2023.
  • Cvs Health's Total Non-Current Liabilities (Quarter) stood at $155.7 billion in 2021, then decreased by 3.81% to $149.8 billion in 2022, then rose by 11.42% to $166.9 billion in 2023, then increased by 3.1% to $172.1 billion in 2024, then increased by 0.77% to $173.4 billion in 2025.
  • Its Total Non-Current Liabilities stands at $173.4 billion for Q4 2025, versus $177.5 billion for Q3 2025 and $176.0 billion for Q2 2025.